Concepts (165)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Drugs, Investigational | 3 | 2024 | 39 | 1.320 |
Why?
|
| Adverse Drug Reaction Reporting Systems | 2 | 2024 | 23 | 1.110 |
Why?
|
| United States Food and Drug Administration | 2 | 2024 | 135 | 0.940 |
Why?
|
| Data Collection | 1 | 2023 | 375 | 0.780 |
Why?
|
| Immunoglobulin A | 6 | 2006 | 83 | 0.530 |
Why?
|
| Immunoglobulin J-Chains | 5 | 2002 | 12 | 0.500 |
Why?
|
| Biological Products | 2 | 2024 | 154 | 0.350 |
Why?
|
| United States | 4 | 2024 | 6965 | 0.290 |
Why?
|
| Colitis, Ulcerative | 2 | 2003 | 736 | 0.260 |
Why?
|
| Cecum | 3 | 2001 | 69 | 0.250 |
Why?
|
| Gastritis | 1 | 2003 | 36 | 0.220 |
Why?
|
| Pseudolymphoma | 1 | 2002 | 9 | 0.210 |
Why?
|
| Measles-Mumps-Rubella Vaccine | 1 | 2002 | 7 | 0.210 |
Why?
|
| Ileal Diseases | 1 | 2002 | 26 | 0.210 |
Why?
|
| Child Development Disorders, Pervasive | 1 | 2002 | 39 | 0.200 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 1 | 2024 | 203 | 0.200 |
Why?
|
| Intestinal Mucosa | 7 | 2006 | 805 | 0.200 |
Why?
|
| Dysgammaglobulinemia | 1 | 2000 | 4 | 0.180 |
Why?
|
| Vaginal Diseases | 1 | 2000 | 28 | 0.180 |
Why?
|
| Herpesvirus 2, Human | 1 | 2000 | 45 | 0.180 |
Why?
|
| Herpes Genitalis | 1 | 2000 | 41 | 0.180 |
Why?
|
| Product Surveillance, Postmarketing | 1 | 2020 | 38 | 0.170 |
Why?
|
| Risk Management | 1 | 2019 | 43 | 0.170 |
Why?
|
| Escherichia coli | 2 | 2001 | 605 | 0.170 |
Why?
|
| Fimbriae Proteins | 1 | 1999 | 15 | 0.160 |
Why?
|
| Fimbriae, Bacterial | 1 | 1999 | 24 | 0.160 |
Why?
|
| Secretory Component | 1 | 1996 | 1 | 0.140 |
Why?
|
| Bacterial Adhesion | 3 | 2001 | 84 | 0.130 |
Why?
|
| Crohn Disease | 1 | 2002 | 758 | 0.120 |
Why?
|
| Rotavirus | 2 | 2006 | 11 | 0.120 |
Why?
|
| Rotavirus Infections | 2 | 2006 | 12 | 0.120 |
Why?
|
| Mice, Inbred BALB C | 6 | 2006 | 1088 | 0.110 |
Why?
|
| Mice | 12 | 2006 | 11743 | 0.110 |
Why?
|
| Mice, Mutant Strains | 4 | 2006 | 231 | 0.110 |
Why?
|
| Heat-Shock Proteins | 2 | 2003 | 183 | 0.100 |
Why?
|
| Aluminum Compounds | 1 | 2011 | 6 | 0.100 |
Why?
|
| Dermatitis, Allergic Contact | 1 | 2011 | 7 | 0.100 |
Why?
|
| Colon | 3 | 2003 | 509 | 0.100 |
Why?
|
| Chlorides | 1 | 2011 | 103 | 0.090 |
Why?
|
| Liver | 1 | 1995 | 1205 | 0.090 |
Why?
|
| Hepatectomy | 3 | 2001 | 170 | 0.090 |
Why?
|
| Vaccines | 1 | 2011 | 83 | 0.090 |
Why?
|
| Enterotoxins | 3 | 2006 | 21 | 0.080 |
Why?
|
| Humans | 10 | 2024 | 89157 | 0.080 |
Why?
|
| Capsid Proteins | 2 | 2006 | 32 | 0.080 |
Why?
|
| Bacterial Toxins | 3 | 2006 | 114 | 0.080 |
Why?
|
| Antigens, Viral | 2 | 2006 | 145 | 0.080 |
Why?
|
| Animals | 12 | 2006 | 27330 | 0.070 |
Why?
|
| Giardia | 1 | 2006 | 1 | 0.070 |
Why?
|
| Giardiasis | 1 | 2006 | 1 | 0.070 |
Why?
|
| Receptors, Polymeric Immunoglobulin | 1 | 2006 | 5 | 0.070 |
Why?
|
| Interleukin-2 | 2 | 2006 | 251 | 0.070 |
Why?
|
| Immunity, Mucosal | 2 | 2006 | 69 | 0.070 |
Why?
|
| Virus Shedding | 1 | 2006 | 27 | 0.070 |
Why?
|
| Therapeutic Equivalency | 1 | 2024 | 14 | 0.060 |
Why?
|
| Enterobacteriaceae | 1 | 2003 | 22 | 0.060 |
Why?
|
| Gastric Mucosa | 1 | 2003 | 66 | 0.050 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2006 | 445 | 0.050 |
Why?
|
| Capsid | 1 | 2002 | 34 | 0.050 |
Why?
|
| Rectum | 1 | 2003 | 148 | 0.050 |
Why?
|
| Base Sequence | 2 | 1996 | 2327 | 0.050 |
Why?
|
| Risk Assessment | 2 | 2020 | 2302 | 0.050 |
Why?
|
| Mice, Knockout | 4 | 2006 | 1990 | 0.050 |
Why?
|
| Molecular Sequence Data | 2 | 1996 | 3027 | 0.050 |
Why?
|
| Mice, Inbred C3H | 1 | 2002 | 371 | 0.050 |
Why?
|
| Child | 2 | 2003 | 7154 | 0.050 |
Why?
|
| Infant | 2 | 2011 | 3149 | 0.050 |
Why?
|
| Antibodies, Viral | 2 | 2006 | 309 | 0.050 |
Why?
|
| Immunoglobulin G | 2 | 2006 | 464 | 0.040 |
Why?
|
| Neoplasm Proteins | 1 | 2003 | 540 | 0.040 |
Why?
|
| Starvation | 1 | 1999 | 23 | 0.040 |
Why?
|
| Cells, Cultured | 3 | 2006 | 2880 | 0.040 |
Why?
|
| Adhesins, Escherichia coli | 1 | 1999 | 3 | 0.040 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2000 | 374 | 0.040 |
Why?
|
| Diagnosis, Differential | 1 | 2003 | 1596 | 0.040 |
Why?
|
| Epithelial Cells | 1 | 2003 | 688 | 0.040 |
Why?
|
| Disease Models, Animal | 2 | 2006 | 2363 | 0.040 |
Why?
|
| Public Health | 1 | 2019 | 138 | 0.040 |
Why?
|
| Cell Line | 2 | 2002 | 2495 | 0.040 |
Why?
|
| Vaccination | 1 | 2000 | 274 | 0.040 |
Why?
|
| Epithelium | 1 | 1999 | 325 | 0.040 |
Why?
|
| beta 2-Microglobulin | 1 | 1997 | 24 | 0.040 |
Why?
|
| Orthomyxoviridae Infections | 1 | 1997 | 46 | 0.040 |
Why?
|
| Immunity, Innate | 1 | 2000 | 429 | 0.030 |
Why?
|
| Milk | 1 | 1996 | 53 | 0.030 |
Why?
|
| Lactation | 1 | 1996 | 54 | 0.030 |
Why?
|
| Influenza A virus | 1 | 1997 | 169 | 0.030 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 1996 | 126 | 0.030 |
Why?
|
| Mammary Glands, Animal | 1 | 1996 | 80 | 0.030 |
Why?
|
| Bile | 1 | 1995 | 57 | 0.030 |
Why?
|
| Restriction Mapping | 1 | 1995 | 156 | 0.030 |
Why?
|
| Nasal Mucosa | 1 | 1996 | 191 | 0.030 |
Why?
|
| Macromolecular Substances | 1 | 1995 | 177 | 0.030 |
Why?
|
| Genes, Immunoglobulin | 1 | 1995 | 111 | 0.030 |
Why?
|
| Delivery of Health Care | 1 | 2019 | 435 | 0.030 |
Why?
|
| T-Lymphocyte Subsets | 1 | 1997 | 275 | 0.030 |
Why?
|
| Biological Transport | 1 | 1995 | 401 | 0.030 |
Why?
|
| DNA Primers | 1 | 1995 | 543 | 0.030 |
Why?
|
| Dogs | 1 | 1995 | 704 | 0.030 |
Why?
|
| Administration, Intranasal | 2 | 2006 | 136 | 0.030 |
Why?
|
| Genotype | 1 | 1999 | 1848 | 0.030 |
Why?
|
| HSP72 Heat-Shock Proteins | 2 | 2003 | 23 | 0.030 |
Why?
|
| Permeability | 2 | 2002 | 137 | 0.030 |
Why?
|
| Patch Tests | 1 | 2011 | 4 | 0.020 |
Why?
|
| Diphtheria-Tetanus-acellular Pertussis Vaccines | 1 | 2011 | 3 | 0.020 |
Why?
|
| Hepatitis B Vaccines | 1 | 2011 | 16 | 0.020 |
Why?
|
| Pneumococcal Vaccines | 1 | 2011 | 28 | 0.020 |
Why?
|
| Immunoglobulin A, Secretory | 2 | 2002 | 18 | 0.020 |
Why?
|
| Female | 5 | 2001 | 46078 | 0.020 |
Why?
|
| Antigens, Protozoan | 1 | 2006 | 21 | 0.020 |
Why?
|
| Cholera Toxin | 1 | 2006 | 21 | 0.020 |
Why?
|
| Lymphocyte Subsets | 1 | 2006 | 66 | 0.020 |
Why?
|
| Vaccines, Synthetic | 1 | 2006 | 55 | 0.020 |
Why?
|
| Immunity | 1 | 2006 | 141 | 0.020 |
Why?
|
| Immunization | 1 | 2006 | 160 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2011 | 2479 | 0.020 |
Why?
|
| Th1 Cells | 1 | 2006 | 166 | 0.020 |
Why?
|
| Feces | 1 | 2006 | 327 | 0.020 |
Why?
|
| Adjuvants, Immunologic | 1 | 2006 | 168 | 0.020 |
Why?
|
| Escherichia coli Proteins | 1 | 2006 | 183 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2006 | 691 | 0.010 |
Why?
|
| Interferon-gamma | 1 | 2006 | 451 | 0.010 |
Why?
|
| Metronidazole | 1 | 2003 | 26 | 0.010 |
Why?
|
| Intestines | 1 | 2006 | 416 | 0.010 |
Why?
|
| Male | 3 | 2011 | 42309 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 2 | 2003 | 3211 | 0.010 |
Why?
|
| CD3 Complex | 1 | 2003 | 134 | 0.010 |
Why?
|
| Caspase 9 | 1 | 2002 | 49 | 0.010 |
Why?
|
| CD28 Antigens | 1 | 2003 | 90 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 2002 | 111 | 0.010 |
Why?
|
| Biological Transport, Active | 1 | 2002 | 102 | 0.010 |
Why?
|
| Glycosylation | 1 | 2002 | 128 | 0.010 |
Why?
|
| Caspases | 1 | 2002 | 155 | 0.010 |
Why?
|
| Molecular Chaperones | 1 | 2003 | 122 | 0.010 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2002 | 85 | 0.010 |
Why?
|
| Viral Vaccines | 1 | 2002 | 44 | 0.010 |
Why?
|
| Adult | 1 | 2002 | 26542 | 0.010 |
Why?
|
| Cattle | 1 | 2002 | 375 | 0.010 |
Why?
|
| Adenosine Triphosphate | 1 | 2002 | 316 | 0.010 |
Why?
|
| Tight Junctions | 1 | 2002 | 150 | 0.010 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2001 | 71 | 0.010 |
Why?
|
| Mannitol | 1 | 2001 | 50 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2002 | 698 | 0.010 |
Why?
|
| Lymphocytes | 1 | 2003 | 471 | 0.010 |
Why?
|
| Electric Impedance | 1 | 2001 | 110 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 2001 | 510 | 0.010 |
Why?
|
| Species Specificity | 1 | 2002 | 684 | 0.010 |
Why?
|
| Actins | 1 | 2002 | 458 | 0.010 |
Why?
|
| Ion Transport | 1 | 1999 | 81 | 0.010 |
Why?
|
| Homeodomain Proteins | 1 | 2003 | 556 | 0.010 |
Why?
|
| Mitochondria | 1 | 2002 | 553 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2003 | 1798 | 0.010 |
Why?
|
| Gene Expression | 1 | 2003 | 1310 | 0.010 |
Why?
|
| Electrophysiology | 1 | 1999 | 403 | 0.010 |
Why?
|
| B-Lymphocytes | 1 | 2002 | 738 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2003 | 786 | 0.010 |
Why?
|
| Mice, Inbred A | 1 | 1997 | 23 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2003 | 2011 | 0.010 |
Why?
|
| Immunization, Passive | 1 | 1997 | 71 | 0.010 |
Why?
|
| Lymphocyte Depletion | 1 | 1997 | 98 | 0.010 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 1997 | 215 | 0.010 |
Why?
|
| Apoptosis | 1 | 2002 | 1717 | 0.010 |
Why?
|
| Virus Replication | 1 | 1997 | 321 | 0.010 |
Why?
|
| Phenotype | 1 | 2001 | 2439 | 0.010 |
Why?
|
| Lung | 1 | 1997 | 1258 | 0.010 |
Why?
|